ABSTRACT
Simultaneous kidney pancreas transplantation (SKP) is a common procedure for the patient with long-term type 1 diabetes mellitus (DM) with terminal renal failure. It is unusual to consider the pancreas from a deceased donor who died after an acute intoxication with oral antidiabetic agent (OAA), which would suggest an abnormal functionality of the organ and preclude the potential use of the graft. We present a case of a successful pancreatic transplantation from a donor who died of acute cerebral edema secondary to severe hypoglycemia induced by OAA acute intoxication.
Subject(s)
Diabetes Mellitus, Type 1/surgery , Diabetic Nephropathies/surgery , Drug Overdose , Glyburide/poisoning , Hypoglycemic Agents/poisoning , Kidney Failure, Chronic/surgery , Kidney Transplantation/methods , Pancreas Transplantation/methods , Tissue Donors , Diabetes Mellitus, Type 1/complications , Female , Humans , Kidney Failure, Chronic/etiology , Male , Middle Aged , Suicide , Treatment OutcomeSubject(s)
Glycine/pharmacology , Liver Circulation/physiology , Liver Transplantation/physiology , Reperfusion Injury/prevention & control , Animals , Graft Survival , Heart Arrest , Humans , Liver Function Tests , Liver Transplantation/mortality , Models, Animal , Survival Analysis , Swine , Time Factors , Transplantation, Homologous/physiologySubject(s)
Diabetes Mellitus, Type 1/surgery , Diabetic Nephropathies/surgery , Drainage/methods , Duodenum/pathology , Pancreas Transplantation/methods , Adolescent , Adult , Drug Therapy, Combination , Female , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/methods , Male , Middle Aged , Postoperative Complications/prevention & controlSubject(s)
Liver Transplantation/physiology , Liver , Adenosine , Adolescent , Adult , Age Factors , Allopurinol , Child , Child, Preschool , Cyclosporine/therapeutic use , Drug Therapy, Combination , Glutathione , Humans , Immunosuppressive Agents/therapeutic use , Infant , Insulin , Liver Transplantation/immunology , Liver Transplantation/mortality , Methylprednisolone/therapeutic use , Organ Preservation/methods , Organ Preservation Solutions , Probability , Raffinose , Survival Rate , Time FactorsABSTRACT
BACKGROUND: The aim of the present study was to evaluate hepatic content of adenine nucleotides and their degradation products in non-heart-beating donor (NHBD) pigs and its relationship with recipient survival. METHODS: Thirty animals were transplanted with an allograft from NHBDs. After warm ischemia (WI) time (20, 30, or 40 min), cardiopulmonary bypass and normothermic recirculation (NR) were run for 30 min. Afterward, the animals were cooled to 15 degrees C and liver procurement was performed. RESULTS: Survival rate was 100% in the 20WI, 70% in the 30WI, and 50% in the 40WI. Livers from non-surviving animals had higher levels of xanthine after NR than livers from surviving animals. Logistic regression analysis revealed that xanthine at the end of NR was the only variable able to predict survival with a calculated sensitivity of 80% and a specificity of 60%. Prolongation of warm ischemic period leaded to a greater xanthine accumulation as well as increased plasma alpha-glutathione S-transferase levels at reperfusion. Xanthine at NR and alpha-glutathione S-transferase at reperfusion significantly correlated, indicating that donor xanthine contributes to some extent to the severity of the lesion by ischemia-reperfusion. CONCLUSIONS: It is suggested that xanthine content in the donor is able to predict survival after transplantation. Xanthine is significantly involved in the hepatic lesion elicited by warm ischemia and subsequent ischemia-reperfusion associated to liver transplantation from a NHBD.
Subject(s)
Liver Transplantation/immunology , Liver/chemistry , Tissue and Organ Procurement/methods , Xanthine/metabolism , Animals , Energy Metabolism , Graft Survival/drug effects , Graft Survival/physiology , Heart Arrest/metabolism , Hypoxanthine/metabolism , Liver Transplantation/mortality , Logistic Models , Survival Rate , Swine , Tissue DonorsABSTRACT
BACKGROUND: To evaluate whether L-arginine reduces liver and biliary tract damage after transplantation from non heart-beating donor pigs. METHODS: Twenty-five animals received an allograft from non-heart-beating donors. After 40 min of cardiac arrest, normothermic recirculation was run for 30 min. The animals were randomly treated with L-arginine (400 mg x kg(-1) during normothermic recirculation) or saline (control group). Then, the animals were cooled and their livers were transplanted after 6 hr of cold ischemia. The animals were killed on the 5th day, liver damage was assessed on wedged liver biopsies by a semiquantitative analysis and by morphometric analysis of the necrotic areas, and biliary tract damage by histological examination of the explanted liver. RESULTS: Seventeen animals survived the study period. The histological parameters assessed (sinusoidal congestion and dilatation, sinusoidal infiltration by polymorphonuclear cells and lymphocytes, endothelitis, dissociation of liver cell plates, and centrilobular necrosis) were significantly worse in the control group. The necrotic area affected 15.9 +/- 14.5% of the liver biopsies in the control group and 3.7 +/- 3.1% in the L-arginine group (P<0.05). Six of eight animal in the control group and only one of eight survivors in the L-arginine group developed ischemic cholangitis (P<0.01). L-Arginine administration was associated with higher portal blood flow (676.9 +/- 149.46 vs. 475.2 +/- 205.6 ml x min x m(-2); P<0.05), higher hepatic hialuronic acid extraction at normothermic recirculation (38.8 +/- 53.7% vs. -4.2 +/- 18.2%; P<0.05) and after reperfusion (28.6 +/- 55.5% vs. -10.9 +/- 15.5%; P<0.05) and lower levels of alpha-glutation-S-transferase at reperfusion (1325 +/- 1098% respect to baseline vs. 6488 +/- 5612%; P<0.02). CONCLUSIONS: L-Arginine administration during liver procurement from non heart beating donors prevents liver and biliary tract damage.
Subject(s)
Arginine/pharmacology , Biliary Tract/blood supply , Heart Arrest , Liver Transplantation/physiology , Liver/blood supply , Tissue and Organ Procurement/methods , Animals , Cardiopulmonary Bypass , Energy Metabolism , Glutathione Transferase/blood , Hyaluronic Acid/blood , Liver/metabolism , Liver/pathology , Liver Circulation/physiology , Liver Transplantation/pathology , Oxygen/metabolism , Regional Blood Flow/physiology , Reperfusion Injury/pathology , Reperfusion Injury/prevention & control , Swine , Tissue DonorsABSTRACT
OBJECTIVE: To assess the ability of clinical or biochemical parameters to predict outcome (survival or non-survival; severe or moderate/no complication) using multiple regression analyses. DESIGN: Prospective, descriptive cohort study with no interventions SETTING: 12 surgical intensive care units of university hospitals and large community hospitals; four medical school research laboratories in eight European countries PATIENTS: 128 surgical patients with major intra-abdominal surgery admitted for at least two days to an intensive care unit MAIN OUTCOME MEASURES: Prediction of complications or survival based on analysis of clinical (Multiple Organ Dysfunction Score, Multi-Organ-Failure Score, Acute Physiology and Chronic Health Evaluation II scores) and immunological (plasma levels of endotoxin, endotoxin neutralizing capacity, IL-6, IL-8, cell associated IL-8, Fc-receptor polymorphism, soluble CD-14) parameters, with comparison of predicted and actual outcomes. RESULTS: APACHE II, MODS score, MOF score, platelets, IL-6, IL-8, ENC, cell ass. IL-8 were significantly different between survivors and non-survivors and patients with/without severe complications by univariate analysis. By multivariate analysis only MOF, MODS score, IL-6, platelets, comorbidity predicted complications with a sensitivity of 82% and a specificity of 87%. Multivariate analysis demonstrated that only APACHE II score, plasma IL-8 and complications predicted death (sensitivity 84%; specificity 90%). CONCLUSION: Immunological surrogate parameters may predict complications and death of surgical ICU patients. The use of several parameters may add to increase sensitivity and specificity in a prognostic model.
Subject(s)
Models, Biological , Multiple Organ Failure/immunology , APACHE , Anti-Bacterial Agents/administration & dosage , Cohort Studies , Endotoxins/blood , Humans , Interleukin-6/blood , Interleukin-8/blood , Lipopolysaccharide Receptors/blood , Multivariate Analysis , Outcome Assessment, Health Care , Prognosis , Prospective Studies , Receptors, Fc/blood , Receptors, Fc/geneticsSubject(s)
Heart Arrest , Liver Transplantation/physiology , Liver , Organ Preservation Solutions , Organ Preservation/methods , Adenosine , Allopurinol , Animals , Disaccharides , Electrolytes , Glutamates , Glutathione , Graft Survival , Histidine , Insulin , Liver Transplantation/pathology , Mannitol , Necrosis , Raffinose , Swine , Tissue Donors , Transplantation, HomologousABSTRACT
Ventilator-associated pneumonia (VAP) is a diffuse polymicrobial and dynamic process, with heterogeneous distribution of lesions, showing different degrees of histological evolution predominating in the dependent lung zones, in which microbiology and histology can be dissociated. This might explain why blind endobronchial techniques to collect respiratory secretions have similar accuracy compared to visually guided samples, explaining the difficulties in validating any methods for its diagnosis. In the clinical setting the association of acute lung injury (ALI) and pneumonia is controversial. However, it is rare to detect diffuse alveolar damage (DAD) in absence of histological signs of pneumonia, probably evidencing that ALI favors the development of pneumonia. Histopathologically, it is difficult to distinguish initial and resolution phases of DAD from pneumonia and vice versa. On the other hand, there is a clear relationship between antimicrobial treatment and the decreased lung bacterial burden which strengthens the importance of distal airway sampling before starting antibiotic therapy.
Subject(s)
Pneumonia/pathology , Animals , Disease Models, Animal , Humans , Pneumonia/etiology , Respiration, Artificial/adverse effects , Respiratory Distress Syndrome/pathology , SwineSubject(s)
Arginine/pharmacology , Graft Survival/physiology , Liver Transplantation/physiology , Liver , Adenosine , Allopurinol , Animals , Biliary Tract/pathology , Glutathione , Graft Survival/drug effects , Heart Arrest , Hepatectomy , Insulin , Liver Transplantation/pathology , Necrosis , Organ Preservation/methods , Organ Preservation Solutions , Raffinose , Swine , Tissue DonorsABSTRACT
UNLABELLED: The aim of this study was to assess liver viability after different periods of cardiac arrest and the predictive value of two markers of ischemia-reperfusion injury. METHODS: A pig liver transplantation model of non-heart-beating donors was studied. Four donor groups were designed; three groups were submitted to different periods of cardiac arrest (20, 30 and 40 min), and the fourth group served as the control group (without cardiac arrest). In the non-heart-beating donor groups, normothermic recirculation was established 30 min prior to total body cooling. Aminotransferase, alpha-glutathione-S-transferase, and hyaluronic acid determinations as well as liver biopsies, were serially performed. RESULTS: Although hepatocellular function could be preserved after 40 min of cardiac arrest, histological lesions at 5 days were considered irreversible due to the presence of a necrotic biliary tract. An overall significant relationship was found between the time period of cardiac arrest (20, 30 or 40 min) and the levels of hyaluronic acid (p = 0.004) or alpha-glutathione-S-transferase (p = 0.01) obtained during liver procurement and transplantation. CONCLUSIONS: The period of cardiac arrest is the determinant factor of liver viability after liver transplantation from non-heart-beating donors. As early markers of endothelial or hepatocellular damage, hyaluronic acid or alpha-glutathione-S-transferase levels may help to evaluate the ischemic injury of a potential donor.
Subject(s)
Heart Arrest , Ischemia/pathology , Liver Circulation , Liver/pathology , Tissue and Organ Procurement , Alanine Transaminase/metabolism , Animals , Aspartate Aminotransferases/metabolism , Endothelium/pathology , Glutathione Transferase/metabolism , Graft Survival , Hyaluronic Acid/metabolism , Ischemia/enzymology , Ischemia/metabolism , Liver/enzymology , Liver/metabolism , Liver Transplantation , Predictive Value of Tests , Survival Analysis , Swine , Time Factors , Tissue SurvivalABSTRACT
The aim of this study was to compare the possible role of normothermic recirculation with the role of liver transplants from non-heart-beating donor pigs after 20 min of cardiac arrest. Three groups were studied, of which two were control groups: group 1, in which the liver was harvested from a heart-beating donor; group 2, in which the liver was harvested after a period of cardiac arrest followed by total body cooling; and group 3, in which the liver was procured as in group 2, but including a period of 30 min of cardiopulmonary bypass and tissue oxygenation at 37 degrees C before total body cooling. Survival at 5 days; endothelial (hyaluronic acid) and hepatocellular damage (AST, ALT, and alpha-GST); adenine nucleotides (energy charge), and histological changes were evaluated. Normothermic recirculation during 30 min showed a significant effect on survival (p = .03), endothelial damage (p < .05), and histological changes after reperfusion (p = .04). Cardiopulmonary bypass significantly increased the energy charge during the normothermic recirculation period (p = .001). Moreover, this study shows that a significant survival (100%) can be achieved with a liver allograft after 20 min of cardiac arrest. Although the liver suffers a major insult in terms of endothelial damage and hepatocellular damage, lesions caused by the ischemic injury are reversible. Histological changes also indicate lesion reversibility, since they almost disappear after 5 days.
Subject(s)
Liver Circulation/physiology , Liver Transplantation , Adenine Nucleotides/metabolism , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Endothelium/pathology , Energy Metabolism , Glutathione Transferase/blood , Graft Survival , Heart Arrest, Induced , Hyaluronic Acid/metabolism , Liver Transplantation/pathology , Liver Transplantation/physiology , Models, Biological , Temperature , Time Factors , Tissue DonorsABSTRACT
BACKGROUND: Our aim was to evaluate the hepatic blood flows and oxygen metabolism of non-heart-beating donor (NHBD) pigs, with the use of cardiopulmonary bypass (CPB) and normothermic recirculation (NR) before total body cooling, and its relationship with recipient survival. METHODS: Thirty-five pigs were transplanted with an allograft from NHBDs. After warm ischemia (WI) time (20, 30, or 40 min), CPB and NR were run for 30 min. After this period, the animals were cooled to 15 degrees C. In the control group (20 min of WI), the period of NR was excluded. Liver procurement was then performed. RESULTS: Survival rate was 100% in the 20WI, 70% in the 30WI, and 50% in the 40WI. Control group survival rate was 0%. Hepatic artery blood flow and portal blood flow recovered during NR. Pump blood flow during CPB increased rapidly during NR and was significantly higher in the 20WI. When donors of the livers transplanted in "surviving pigs" (DSP) were compared with donors of the livers transplanted in "nonsurviving pigs" (DNSP), hepatic artery blood flow, portal blood flow, and pump blood flow were higher in the DSP. Hepatic oxygen extraction ratio increased in the three groups with respect to baseline values. Hepatic oxygen extraction ratio was lower in the 20WI than in the other groups and was lower in the DSP than in the DNSP. CONCLUSIONS: The use of a NR period before total body cooling improves survival of liver transplantation in NHBDs. Portal blood flow and pump blood flow measurements can predict the viability of the grafts.
Subject(s)
Cardiopulmonary Bypass , Liver Circulation , Liver Transplantation , Oxygen/metabolism , Animals , Survival Rate , SwineABSTRACT
The aim of this study was to evaluate the influence of preserving the recipient's inferior vena cava during orthotopic liver transplantation (OLT) on hemodynamic alterations, blood component requirements, postoperative liver and renal function, as well as vascular-related complications. A total of 122 OLTs was studied. In 35 OLTs, venovenous bypass (BP) was used; in 35 OLTs, bypass was not used (NBP); and in 52 OLTs, the recipient's inferior vena cava was preserved (PC). Preservation of the inferior vena cava means that venous return is not compromised at any time during transplantation. The time of hepatectomy was not different among the three groups (208 +/- 11, 188 +/- 13, and 194 +/- 6 minutes for BP, NBP, and PC, respectively); however, the total operating time was significantly lower in PC patients (492 +/- 24, 459 +/- 18, and 419 +/- 10 minutes for BP, NBP, and PC, respectively; P = .004, ANOVA). Blood component requirements were significantly lower in patients with PC. For red blood cells, these were 15.2 +/- 2.6, 16 +/- 3.4, and 7.1 +/- 1.5 units for BP, NBP, and PC, respectively (P = .009, ANOVA), and for fresh-frozen plasma, these were 5.4 +/- .7, 5.8 +/- .9, and 3 +/- .4 L for BP, NBP, and PC, respectively (P = .005, ANOVA). Postoperative liver and renal function did not differ among the three groups. The incidence of surgical complications (bleeding and vascular) was similar. Preservation of the inferior vena cava of the recipient significantly reduces the magnitude of OLT.